Skip to content

news

The Hatchet – SMHS fourth-year addresses disparities in cancer treatment for HIV patients in new initiative

/the-hatchet-smhs-fourth-year-addresses-disparities-in-cancer-treatment-for-hiv-patients-in-new-initiative

publication

Beyond Breakthrough: Optimizing the Breakthrough Therapy Designation

/beyond-breakthrough-optimizing-the-breakthrough-therapy-designation

news

Cancer Therapy Advisor – RACE Act Increases Required Pediatric Studies for Cancer Drugs

/cancer-therapy-advisor-race-act-increases-required-pediatric-studies-for-cancer-drugs

news

SelectScience – RACE act increased the number of cancer drugs with required studies for use in pediatric patients

/selectscience-race-act-increased-the-number-of-cancer-drugs-with-required-studies-for-use-in-pediatric-patients

news

Medscape – More Drugs Tested in Pediatric Cancer: RACE for Children Act

/medscape-more-drugs-tested-in-pediatric-cancer-race-for-children-act

news

Healio – RACE Act led to more required pediatric studies of cancer drugs

/healio-race-act-led-to-more-required-pediatric-studies-of-cancer-drugs

news

AACR – RACE Act Increased the Number of Cancer Drugs with Required Studies for Use in Pediatric Patients

/aacr-race-act-increased-the-number-of-cancer-drugs-with-required-studies-for-use-in-pediatric-patients

news

GlobeNewswire – Bionano Genomics Announces Release of Version 6.2 of its NxClinical Software with Significant New Capabilities for Cancer Research Applications Including HRD Analysis

/globenewswire-bionano-genomics-announces-release-of-version-6-2-of-its-nxclinical-software-with-significant-new-capabilities-for-cancer-research-applications-including-hrd-analysis

post

Optimizing Dosing in Oncology Drug Development Q & A

/optimizing-dosing-in-oncology-drug-development

news

Oncology Times – Biomarker-Driven Development of Diagnostics for Rare Diseases

/oncology-times-biomarker-driven-development-of-diagnostics-for-rare-diseases